The Patent Finder

Hybrigenics S.A.

Also on record
Records under this name other than the patents Hybrigenics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Hybrigenics S.A.

PatentTitleStatus Expires Confidence
US 8,481,514Therapeutical uses of inecalcitol
Lapsed on the fee record
Ended Jul 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 9, 2025From the USPTO record
US 9,546,150Substituted quinazolin-4-ones for inhibiting ubiquitin specific protease 7
Lapsed on the fee record
Ended Jan 17, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 17, 2025From the USPTO record
US 9,315,455Process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the same
Lapsed on the fee record
Ended Apr 19, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 19, 2024From the USPTO record
US 7,875,613Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
Lapsed on the fee record
Ended Jan 25, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 25, 2023From the USPTO record
US 10,111,896Composition Comprising a Combination of DNA Methylation Inhibitor and a Vitamin D Receptor Agonist for the Treatment of Drug Resistant Cancer or for the Prevention of Tumor Relapse
Lapsed on the fee record
Ended Oct 30, 2022 · High confidence
Lapsed on the fee recordEnded Oct 30, 2022High confidence
US 7,763,254Human Immunodeficiency Virus Integrase-Ledgf P75 Isoform Protein-Protein Interactions.
Formerly held
Lapsed on the fee record
Ended Jul 27, 2022 · High confidence
Lapsed on the fee recordEnded Jul 27, 2022High confidence
US 8,648,076Cysteine protease inhibitors and their therapeutic applications
Lapsed on the fee record
Ended Feb 11, 2022 · From the USPTO record
Lapsed on the fee recordEnded Feb 11, 2022From the USPTO record
US 7,462,615Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
Lapsed on the fee record
Ended Dec 9, 2020 · From the USPTO record
Lapsed on the fee recordEnded Dec 9, 2020From the USPTO record
US 6,916,615Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof
Term ended
Term ended Jul 3, 2020 · From the USPTO record
Term endedTerm ended Jul 3, 2020From the USPTO record
US 9,328,093Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications
Lapsed on the fee record
Ended May 3, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 3, 2020From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited